New ways to screen and predict outcomes for HIV-related cancers in Malawi and South Africa
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa
This study is working to find better ways to detect and understand cancers linked to HIV, like Kaposi sarcoma, cervical cancer, and lymphoma, in Malawi and South Africa, so that people living with HIV can get the help they need more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10891536 on NIH RePORTER |
What this research studies
This research focuses on improving the screening and prognosis of HIV-associated cancers, specifically Kaposi sarcoma, cervical cancer, and lymphoma, in Malawi and South Africa. It aims to establish the UNC-Malawi-South Africa Cancer Consortium to enhance research capacity and conduct impactful studies in these regions. By leveraging existing collaborations and infrastructure, the project seeks to address the significant cancer burden faced by individuals living with HIV. The approach includes innovative methods tailored to the unique challenges of these populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are at risk for or diagnosed with Kaposi sarcoma, cervical cancer, or lymphoma.
Not a fit: Patients who do not have HIV or are not at risk for the specified cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better screening techniques and prognostic tools for HIV-related cancers, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown promise in improving outcomes for HIV-related cancers, indicating that this approach could build on established findings.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Damania, Blossom a — Univ of North Carolina Chapel Hill
- Study coordinator: Damania, Blossom a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.